NOVO HOLDINGS A/S sold 0.2% of their position (6.40K shares) of CYTEIR THERAPEUTICS, INC. on the open market
Open‑market sale worth $13.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/14/2023ACC: 0001209191-23-037208
10% Owner
Since Jun 2021
-6.40K
Net shares
Net seller
$13.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
6.40K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−900.00
Price / share
$2.06
Trade value
$1.86K
% of position
0.0%
6/12/2023
3.94M→3.94M
Common Stock
Direct
Shares
−2.63K
Price / share
$2.10
Trade value
$5.51K
% of position
0.1%
6/13/2023
3.94M→3.94M
Common Stock
Direct
Shares
−2.87K
Price / share
$2.11
Trade value
$6.05K
% of position
0.1%
6/14/2023
3.94M→3.93M
Total
Net shares
−6.40K
Net value
-$13.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2023 | S · Sale | −900.00 | $2.06 | $1.86K | 0.0% | 3.94M | 3.94M |
| Common Stock Direct | 6/13/2023 | S · Sale | −2.63K | $2.10 | $5.51K | 0.1% | 3.94M | 3.94M |
| Common Stock Direct | 6/14/2023 | S · Sale | −2.87K | $2.11 | $6.05K | 0.1% | 3.94M | 3.93M |
| Total | −6.40K | -$13.42K | ||||||
Derivative Transactions0
No derivative transactions reported